• No results found

Anti-VEGF THERAPY:

Pazopanib and anti-VEGF therapy

Pazopanib and anti-VEGF therapy

... to VEGF biology and anti-VEGF therapy Following the pioneering work of the late Judah Folkman demonstrating the role of angiogenesis in tumor development, the treatment of metastatic cancer ...

6

Advances in MRI assessment of gliomas and response to anti-VEGF therapy.

Advances in MRI assessment of gliomas and response to anti-VEGF therapy.

... The functional diffusion map (fDM) was developed to take advantage of the relationship between ADC and cell density by examining voxel-wise changes in ADC mea- sured in the same patient over time [ 24 – 27 ]. By ...

10

Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD

Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD

... Switching anti-VEGF therapy to aflibercept in patients with neovascular AMD who were showing insufficient anatomic response with ranibizumab or bevacizumab was accompanied by a reduction of central ...

6

Role of Diabetic Retinopathy Stage in the Outcome of Anti-VEGF Therapy in Macular Edema

Role of Diabetic Retinopathy Stage in the Outcome of Anti-VEGF Therapy in Macular Edema

... between anti-VEGF and laser ...of anti-VEGF therapy while controlling for demographic and clinical ...from anti-VEGF injections to laser surgery were more likely to be ...

5

Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review

Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review

... of anti-VEGF agents have been recommended as a first-line treatment for neovascular ...standardized anti-VEGF ...to anti-VEGF therapy, which results in a diminished ...

11

Submacular predominantly hemorrhagic choroidal neovascularization: resolution of bleedings under anti-VEGF therapy

Submacular predominantly hemorrhagic choroidal neovascularization: resolution of bleedings under anti-VEGF therapy

... In a large retrospective case series, eyes with subretinal bleedings secondary to typical AMD and polypoidal choroi- dal vasculopathy after anti-VEGF therapy were analyzed. 19 In 91 eyes, the mean ...

5

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy

... The unexpectedly significant progression of all forms of cataracts resulted in an associated diminishment in VA and MP values. Previous studies of eyes with RVO have demon- strated significant improvements in VA ...

8

Inflammatory Choroidal Neovascular Membranes in Patients With Noninfectious Uveitis: The Place Of Intravitreal Anti-VEGF Therapy

Inflammatory Choroidal Neovascular Membranes in Patients With Noninfectious Uveitis: The Place Of Intravitreal Anti-VEGF Therapy

... Correspondence to: Prof Ali Osman Saatci MD, Mustafa Kemal Sahil Bulvarı. No: 73 A Blok, Daire: 9, Narlıdere, 35320, Izmir/Turkey. Tel: +905327437071. E-mail: [email protected] How to cite this article: Karti O, ...

9

A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration

A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration

... of therapy (ie, a prognostic marker) 7,8,13 ...standard anti-VEGF therapy; thus making it a powerful predictive biomarker as ...after anti-VEGF injections compared with the ...

7

Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study

Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study

... of anti-VEGF therapy is not obviously correlated with functional outcome, since the latter can be compromised by persistent structural change in the fovea including ellipsoid zone disruption or ...

8

Optical coherence tomography  parameters predictive of visual outcome after anti-VEGF therapy for retinal vein occlusion

Optical coherence tomography parameters predictive of visual outcome after anti-VEGF therapy for retinal vein occlusion

... The thicker CRT, which represents the severity of ME, may lead to a disruption of the ELM integrity and damage the photoreceptors. 9 The multiple regression analyses showed that the pre- treatment MV had the highest ...

9

Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy

Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy

... combination therapy based on “action-reaction” theory ...of anti- VEGF ...during anti-VEGF therapy, may provide insights into GBM pathobiology and development of more effective ...

12

Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources

Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources

... decade, anti-vascular endothelial growth factor (anti-VEGF) therapy has replaced photo- dynamic therapy and laser photocoagulation as the standard of care for treatment of these ...

12

An eighteen-month follow-up study on the effects of intravitreal dexamethasone implant in diabetic macular edema refractory to anti-VEGF therapy

An eighteen-month follow-up study on the effects of intravitreal dexamethasone implant in diabetic macular edema refractory to anti-VEGF therapy

... · CONCLUSION: Our findings demonstrate that Intravitreal Dexamethasone Implant is a good option to improve BCVA and CMT in DME patients resistant to anti -VEGF therapy. Our data also show that the ...

6

Tumor refractoriness to anti-VEGF therapy

Tumor refractoriness to anti-VEGF therapy

... of anti-angiogenic therapies targeting VEGF and its receptors are very modest, resulting in a moderate improvement of overall ...to VEGF pathway inhibitors, including normalization of tumor blood ...

10

Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration

Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration

... of anti- vascular endothelial growth factor (VEGF) are the standard treatment for wet ...encoding VEGF pathway members contribute to therapy ...with anti- VEGF was genotyped for ...

8

Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer

Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer

... OS after first-line therapy was affected by regimens of subsequent chemotherapy or targeted therapy. As for che- motherapy, irinotecan and oxaliplatin alone or coupled with FU and LV are cornerstone drugs ...

7

Silencing NIK potentiates anti-VEGF therapy in a novel 3D model  of colorectal cancer angiogenesis

Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis

... as VEGF, in addition to alternative facilitators, such as inflammatory ...to anti-VEGF treatment xenografted onto mice were subsequently treated with a combination of a VEGF- and an IL-6 ...

11

Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study

Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study

... second-line therapy after initial VEGF-targeted therapy still are ...initial VEGF-targeted therapy in patients with mRCC in the routine clinical setting in ...

10

Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy

Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy

... extracellular VEGF gradients is believed to be important for normal vascular ...81 VEGF regulates tip cell forma- tion by inducing Dll4 expression in endothelial ...regulates VEGF-mediated angio- ...

10

Show all 10000 documents...

Related subjects